Geode Capital Management
DERM icon

Geode Capital Management’s Journey Medical DERM Stock Holding History

Geode Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Buy
463,202
+149,232
+48% +$1.16M ﹤0.01% 3086
2025
Q4 		$2.42M Buy
313,970
+36,124
+13% +$283K ﹤0.01% 3097
2025
Q3 		$1.98M Buy
277,846
+15,493
+6% +$112K ﹤0.01% 3184
2025
Q2 		$1.88M Buy
262,353
+148,612
+131% +$1.03M ﹤0.01% 3166
2025
Q1 		$671K Buy
113,741
+4,525
+4% +$22.2K ﹤0.01% 3438
2024
Q4 		$427K Buy
109,216
+781
+0.7% +$4.27K ﹤0.01% 3654
2024
Q3 		$613K Buy
108,435
+12,882
+13% +$66.3K ﹤0.01% 3529
2024
Q2 		$539K Buy
95,553
+6,478
+7% +$26.7K ﹤0.01% 3544
2024
Q1 		$328K Buy
89,075
+3,290
+4% +$14.3K ﹤0.01% 3767
2023
Q4 		$494K Buy
85,785
+16,276
+23% +$72.5K ﹤0.01% 3615
2023
Q3 		$191K Buy
69,509
+40,015
+136% +$89.4K ﹤0.01% 4002
2023
Q2 		$46.9K Hold
29,494
– – ﹤0.01% 4516
2023
Q1 		$46.3K Sell
29,494
-438
-1% -$817 ﹤0.01% 4537
2022
Q4 		$57K Buy
29,932
+2,377
+9% +$4.7K ﹤0.01% 4556
2022
Q3 		$67K Buy
+27,555
New +$93.9K ﹤0.01% 4700

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Geode Capital Management's DERM Position: Q1 2026 in Review

Geode Capital Management increased its Journey Medical (DERM) stake by 48% in Q1 2026, buying an estimated $1.16M and bringing the position to 463,202 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

Geode Capital Management first reported a position in DERM in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.42M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Geode Capital Management held 463,202 shares of Journey Medical worth $2.17M as of Q1 2026.
  • Geode Capital Management bought 149,232 Journey Medical shares in Q1 2026, an estimated $1.16M.
  • Journey Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3086 holding.
  • Geode Capital Management first reported a position in Journey Medical in Q3 2022 and has held it in 15 quarters since.
  • Geode Capital Management's Journey Medical position peaked at $2.42M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.